To hear M&A professionals and dealmakers tell it, 2016 promises to be as strong in terms of volume and deal size as last year. Morgan Lewis has prepared a series of tailored webinars led by a diverse team of lawyers to provide an overview of the most critical developments we think you need to be aware of. Whether you are an M&A lawyer, a businessperson, or a specialist in other areas (including employee benefits, intellectual property, and tax), we think you’ll find the program that is most useful for you and your business to stay ahead of the curve.
View all M&A Academy webinars offered through June and sign up. CLE credit is available. Read on for a sneak preview below.
Presented by New York partner Bradley Edmister, who represents US, Japanese, and other Asian clients in cross-border mergers and acquisitions and capital markets transactions.
Program highlights: Countless cross-border deals stumble for entirely avoidable reasons. Bradley will discuss the importance of adapting to local markets and customs, including the myriad “unwritten rules” in every culture. He’ll also cover the extra burdens of interfacing with local councils and advisors, decrypting unfamiliar legal regimes, reading the tea leaves of enforceability and dispute resolution, and planning for post-transaction governance, restructuring and compliance, and you have a perfect recipe to keep any general counsel or deal principal up at night.
Presented by Boston partners Jack Concannon, who has more than 25 years of experience representing life sciences clients ranging from emerging growth companies to global corporations in general corporate and securities law, mergers and acquisitions, venture capital financings, public offerings, joint ventures, and licensing; Carl Valenstein, who counsels public and private life sciences companies on corporate and securities, M&A, financing and other transactional work, including licensing and collaboration agreements; Washington, DC partner Kathy Sanzo, who represents clients in the pharmaceuticals and biotechnology industries in regulatory and compliance matters connected to products regulated by the US Food and Drug Administration (FDA); and San Francisco partner Robin Silva, who counsels start-ups, emerging and public companies, and other biotechnology clients in domestic and international matters focusing on IP portfolio strategic development.
Program highlights: Jack, Carl, Kathy, and Robin will address three main areas:
Presented by Washington, DC partner Margaret Gatti, who assists US and non-US clients in a broad range of matters involving everything from economic sanctions and export controls to customs and import regulations, to free trade agreements and international e-commerce; and Boston partner Carl Valenstein, who, among other matters, advises clients on international risk management, including compliance with the foreign investment review process, export control and sanctions, anti-money laundering, anti-boycott, and anticorruption laws and regulations.
Program highlights: Carl and Margaret will address the following key issues and provide tips for reducing risks:
Presented by Boston partner Jordan Hershman, Morgan Lewis’s securities litigation leader who focuses on securities class action and derivative action litigation, related regulatory and enforcement proceedings, merger and acquisition litigation, and other complex business and intellectual property disputes; Hartford partner Michael Blanchard, who represents clients in all facets of securities litigation, securities enforcement actions, and internal investigations; and Los Angeles partner Stephen Alexander, whose practice includes a broad range of significant business litigation, with particular emphasis on securities, derivative, corporate governance, and acquisition-related matters and proxy contests.
Program highlights: Jordan, Michael, and Stephen will discuss the hot-button issues raised by the following landmark decision:
Don’t miss these and other upcoming M&A Academy webinars. Registration is easy.